Repligen reported $114.23M in Gross Profit on Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Agilent A:US USD 1.01B 73M
Align Technology ALGN:US USD 619.17M 68.39M
Biomarin Pharmaceutical BMRN:US USD 389.06M 21.62M
Bristol Myers Squibb BMY:US USD 8.86B 345M
Bruker BRKR:US USD 335.1M 35.6M
Catalent CTLT:US USD 258M 230M
Charles River Laboratories CRL:US USD 370.22M 13.5M
Danaher DHR:US USD 4.58B 137M
Dentsply International XRAY:US USD 508M 73M
Exact Sciences EXAS:US USD 375.14M 1.9M
Fluidigm FLDM:US USD 9.22M 4.79M
General Electric GE:US USD 4.42B 618M
Henry Schein HSIC:US USD 914M 31M
Illumina ILMN:US USD 717M 50M
IQVIA Holdings Inc IQV:US USD 1.24B 31M
Mettler Toledo International MTD:US USD 584.66M 13M
Myriad Genetics MYGN:US USD 106M 23.6M
Orasure Technologies OSUR:US USD 46.19M 18.61M
Patterson Companies PDCO:US USD 312.13M 36.11M
Peregrine Pharmaceuticals PPHM:US USD 9.12M 2.13M
Pfizer PFE:US USD 16.55B 2.52B
Repligen RGEN:US USD 114.23M 7.15M
Thermo Fisher Scientific TMO:US USD 4.43B 168M
Waters WAT:US USD 401.45M 5.66M
West Pharmaceutical Services WST:US USD 268M 53.5M